<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36690069</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8638</ISSN><JournalIssue CitedMedium="Internet"><Volume>435</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of molecular biology</Title><ISOAbbreviation>J Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Interactions between FUS and the C-terminal Domain of Nup62 are Sufficient for their Co-phase Separation into Amorphous Assemblies.</ArticleTitle><Pagination><StartPage>167972</StartPage><MedlinePgn>167972</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmb.2023.167972</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-2836(23)00028-1</ELocationID><Abstract><AbstractText>Deficient nucleocytoplasmic transport is emerging as a pathogenic feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), including in ALS caused by mutations in Fused in Sarcoma (FUS). Recently, both wild-type and ALS-linked mutant FUS were shown to directly interact with the phenylalanine-glycine (FG)-rich nucleoporin 62 (Nup62) protein, where FUS WT/ Nup62 interactions were enriched within the nucleus but ALS-linked mutant FUS/ Nup62 interactions were enriched within the cytoplasm of cells. Nup62 is a central channel Nup that has a prominent role in forming the selectivity filter within the nuclear pore complex and in regulating effective nucleocytoplasmic transport. Under conditions where FUS phase separates into liquid droplets in vitro, the addition of Nup62 caused the synergistic formation of amorphous assemblies containing both FUS and Nup62. Here, we examined the molecular determinants of this process using recombinant FUS and Nup62 proteins and biochemical approaches. We demonstrate that the structured C-terminal domain of Nup62 containing an alpha-helical coiled-coil region plays a dominant role in binding FUS and is sufficient for inducing the formation of FUS/Nup62 amorphous assemblies. In contrast, the natively unstructured, F/G repeat-rich N-terminal domain of Nup62 modestly contributed to FUS/Nup62 phase separation behavior. Expression of individual Nup62 domain constructs in human cells confirmed that the Nup62 C-terminal domain is essential for localization of the protein to the nuclear envelope. Our results raise the possibility that interactions between FUS and the C-terminal domain of Nup62 can influence the function of Nup62 under physiological and/or pathological conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Meenakshi Sundaram</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, MA 01605, USA; Biochemistry and Molecular Biotechnology Program, Morningside Graduate School of Biomedical Sciences, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallworth</LastName><ForeName>Karly M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, MA 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murthy</LastName><ForeName>Anastasia C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Su Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Aastha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munro</LastName><ForeName>James B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fawzi</LastName><ForeName>Nicolas L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagier-Tourenne</LastName><ForeName>Clotilde</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosco</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, MA 01605, USA. Electronic address: Daryl.Bosco@umassmed.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM137529</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS120126</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM147677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS108769</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM118530</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Mol Biol</MedlineTA><NlmUniqueID>2985088R</NlmUniqueID><ISSNLinking>0022-2836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C049312">nuclear pore protein p62</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028861">Nuclear Pore Complex Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="Y">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="Y">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="Y">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028861" MajorTopicYN="Y">Nuclear Pore Complex Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)</Keyword><Keyword MajorTopicYN="N">fused in sarcoma (FUS)</Keyword><Keyword MajorTopicYN="N">nucleocytoplasmic transport</Keyword><Keyword MajorTopicYN="N">nucleoporin 62 (Nup62)</Keyword><Keyword MajorTopicYN="N">phase separation</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>23</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36690069</ArticleId><ArticleId IdType="mid">NIHMS1871735</ArticleId><ArticleId IdType="pmc">PMC10329203</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2023.167972</ArticleId><ArticleId IdType="pii">S0022-2836(23)00028-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt HB, and Gorlich D.(2016) Transport Selectivity of Nuclear Pores, Phase Separation, and Membraneless Organelles. Trends Biochem Sci 41, 46&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">26705895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Khalil B, Smith CL, and Rossoll W.(2020) Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis 140, 104835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, and Rothstein JD (2022) Nuclear pore complexes - a doorway to neural injury in neurodegeneration. Nat Rev Neurol 18, 348&#x2013;362</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10015220</ArticleId><ArticleId IdType="pubmed">35488039</ArticleId></ArticleIdList></Reference><Reference><Citation>Spead O, Zaepfel BL, and Rothstein JD (2022) Nuclear Pore Dysfunction in Neurodegeneration. Neurotherapeutics 10.1007/s13311-022-01293-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01293-w</ArticleId><ArticleId IdType="pmc">PMC9587172</ArticleId><ArticleId IdType="pubmed">36070178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Kumar MS, Ramesh N, Anderson EN, Nguyen AT, Kim B, Cheung S, McDonough JA, Skarnes WC, Lopez-Gonzalez R, Landers JE, Fawzi NL, Mackenzie IRA, Lee EB, Nickerson JA, Grunwald D, Pandey UB, and Bosco DA (2021) Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat Neurosci 24, 1077&#x2013;1088</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RR, Ward CL, and Bosco DA (2014) Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro 6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4189536</ArticleId><ArticleId IdType="pubmed">25289647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, Neumann M, and Haass C.(2010) ALSassociated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841&#x2013;2857</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurt EC (1988) A novel nucleoskeletal-like protein located at the nuclear periphery is required for the life cycle of Saccharomyces cerevisiae. EMBO J 7, 4323&#x2013;4334</Citation><ArticleIdList><ArticleId IdType="pmc">PMC455148</ArticleId><ArticleId IdType="pubmed">3072197</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawn LA, Shen T, Shulga N, Goldfarb DS, and Wente SR (2004) Minimal nuclear pore complexes define FG repeat domains essential for transport. Nat Cell Biol 6, 197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="pubmed">15039779</ArticleId></ArticleIdList></Reference><Reference><Citation>Basel-Vanagaite L, Muncher L, Straussberg R, Pasmanik-Chor M, Yahav M, Rainshtein L, Walsh CA, Magal N, Taub E, Drasinover V, Shalev H, Attia R, Rechavi G, Simon AJ, and Shohat M.(2006) Mutated nup62 causes autosomal recessive infantile bilateral striatal necrosis. Ann Neurol 60, 214&#x2013;222</Citation><ArticleIdList><ArticleId IdType="pubmed">16786527</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, DeTure M, Vanderburg CR, Corjuc BT, DeVos SL, Gonzalez JA, Chew J, Vidensky S, Gage FH, Mertens J, Troncoso J, Mandelkow E, Salvatella X, Lim RYH, Petrucelli L, Wegmann S, Rothstein JD, and Hyman BT (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer&#x2019;s Disease. Neuron 99, 925&#x2013;940 e927</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240334</ArticleId><ArticleId IdType="pubmed">30189209</ArticleId></ArticleIdList></Reference><Reference><Citation>Grima JC, Daigle JG, Arbez N, Cunningham KC, Zhang K, Ochaba J, Geater C, Morozko E, Stocksdale J, Glatzer JC, Pham JT, Ahmed I, Peng Q, Wadhwa H, Pletnikova O, Troncoso JC, Duan W, Snyder SH, Ranum LPW, Thompson LM, Lloyd TE, Ross CA, and Rothstein JD (2017) Mutant Huntingtin Disrupts the Nuclear Pore Complex. Neuron 94, 93&#x2013;107 e106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5595097</ArticleId><ArticleId IdType="pubmed">28384479</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Chillon-Marinas C, Goginashvili A, Atwal RS, Artates JW, Tabet R, Wheeler VC, Bang AG, Cleveland DW, and Lagier-Tourenne C.(2017) Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport. Neuron 94, 48&#x2013;57 e44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5479704</ArticleId><ArticleId IdType="pubmed">28384474</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, and Gage FH (2001) Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol 153, 283&#x2013;294</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169460</ArticleId><ArticleId IdType="pubmed">11309410</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson EN, Morera AA, Kour S, Cherry JD, Ramesh N, Gleixner A, Schwartz JC, Ebmeier C, Old W, Donnelly CJ, Cheng JP, Kline AE, Kofler J, Stein TD, and Pandey UB (2021) Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology. Elife 10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169113</ArticleId><ArticleId IdType="pubmed">34060470</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleixner AM, Verdone BM, Otte CG, Anderson EN, Ramesh N, Shapiro OR, Gale JR, Mauna JC, Mann JR, Copley KE, Daley EL, Ortega JA, Cicardi ME, Kiskinis E, Kofler J, Pandey UB, Trotti D, and Donnelly CJ (2022) NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility. Nat Commun 13, 3380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9192689</ArticleId><ArticleId IdType="pubmed">35697676</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B, Hartmann H, May S, Mohl C, Ederle H, Michaelsen M, Schludi MH, Dormann D, and Edbauer D.(2017) Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD. Hum Mol Genet 26, 790&#x2013;800</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke Kathleen A., Janke Abigail M., Rhine Christy L., and Fawzi Nicolas L. (2015) Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. Molecular Cell 60, 231&#x2013;241</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee, Hyun O, Jawerth L, Maharana S, Jahnel M, Hein Marco Y., Stoynov S, Mahamid J, Saha S, Franzmann Titus M., Pozniakovski A, Poser I, Maghelli N, Royer Loic A., Weigert M, Myers Eugene W., Grill S, Drechsel D, Hyman Anthony A., and Alberti S.(2015) A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell 162, 1066&#x2013;1077</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey JL, and Guo L.(2022) Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases. Front Mol Biosci 9, 826719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847598</ArticleId><ArticleId IdType="pubmed">35187086</ArticleId></ArticleIdList></Reference><Reference><Citation>Solmaz SR, Chauhan R, Blobel G, and Melcak I.(2011) Molecular architecture of the transport channel of the nuclear pore complex. Cell 147, 590&#x2013;602</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431207</ArticleId><ArticleId IdType="pubmed">22036567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich A, Partridge JR, and Schwartz TU (2014) The stoichiometry of the nucleoporin 62 subcomplex of the nuclear pore in solution. Mol Biol Cell 25, 1484&#x2013;1492</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4004597</ArticleId><ArticleId IdType="pubmed">24574455</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarkson WD, Kent HM, and Stewart M.(1996) Separate binding sites on nuclear transport factor 2 (NTF2) for GDP-Ran and the phenylalanine-rich repeat regions of nucleoporins p62 and Nsp1p. J Mol Biol 263, 517&#x2013;524</Citation><ArticleIdList><ArticleId IdType="pubmed">8918934</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DH, and Hoelz A.(2019) The Structure of the Nuclear Pore Complex (An Update). Annu Rev Biochem 88, 725&#x2013;783</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588426</ArticleId><ArticleId IdType="pubmed">30883195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chug H, Trakhanov S, Hulsmann BB, Pleiner T, and Gorlich D.(2015) Crystal structure of the metazoan Nup62*Nup58*Nup54 nucleoporin complex. Science 350, 106&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pubmed">26292704</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuwe T, Bley CJ, Thierbach K, Petrovic S, Schilbach S, Mayo DJ, Perriches T, Rundlet EJ, Jeon YE, Collins LN, Huber FM, Lin DH, Paduch M, Koide A, Lu V, Fischer J, Hurt E, Koide S, Kossiakoff AA, and Hoelz A.(2015) Architecture of the fungal nuclear pore inner ring complex. Science 350, 56&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4826903</ArticleId><ArticleId IdType="pubmed">26316600</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth W, Chatterjee S, and Stochaj U.(1999) Targeting of the mammalian nucleoporin p62 to the nuclear envelope in the yeast Saccharomyces cerevisiae and HeLa cells. Biochem Cell Biol 77, 355&#x2013;365</Citation><ArticleIdList><ArticleId IdType="pubmed">10546899</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo-Fonseca M, Kern H, and Hurt EC (1991) Human nucleoporin p62 and the essential yeast nuclear pore protein NSP1 show sequence homology and a similar domain organization. Eur J Cell Biol 55, 17&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">1915414</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke KA, Janke AM, Rhine CL, and Fawzi NL (2015) Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. Mol Cell 60, 231&#x2013;241</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, Boeynaems S, Kato M, Guo L, Caulfield TR, Steyaert J, Scheveneels W, Wilmans N, Haeck W, Hersmus N, Schymkowitz J, Rousseau F, Shorter J, Callaerts P, Robberecht W, Van Damme P, and Van Den Bosch L.(2017) Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity. Cell Rep 24, 529&#x2013;537 e524</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M, Ruepp MD, Simons M, Niessing D, Madl T, and Dormann D.(2018) Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation. Cell 173, 706&#x2013;719 e713</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, Phillips EC, Miyashita A, Williams D, Strohl F, Meadows W, Ferry R, Dardov VJ, Tartaglia GG, Farrer LA, Kaminski Schierle GS, Kaminski CF, Holt CE, Fraser PE, Schmitt-Ulms G, Klenerman D, Knowles T, Vendruscolo M, and St George-Hyslop P.(2018) FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-pi Interactions. Cell 173, 720&#x2013;734 e715</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Choi JM, Holehouse AS, Lee HO, Zhang X, Jahnel M, Maharana S, Lemaitre R, Pozniakovsky A, Drechsel D, Poser I, Pappu RV, Alberti S, and Hyman AA (2018) A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins. Cell 174, 688&#x2013;699 e616</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T, Ali R, Jiou J, Fung HYJ, Burke KA, Kim SJ, Lin Y, Peeples WB, Saltzberg D, Soniat M, Baumhardt JM, Oldenbourg R, Sali A, Fawzi NL, Rosen MK, and Chook YM (2018) Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites. Cell 173, 693&#x2013;705 e622</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy AC, Tang WS, Jovic N, Janke AM, Seo DH, Perdikari TM, Mittal J, and Fawzi NL (2021) Molecular interactions contributing to FUS SYGQ LC-RGG phase separation and co-partitioning with RNA polymerase II heptads. Nat Struct Mol Biol 28, 923&#x2013;935</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8654040</ArticleId><ArticleId IdType="pubmed">34759379</ArticleId></ArticleIdList></Reference><Reference><Citation>Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, and Kaufman PD (2009) A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4, e6529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717805</ArticleId><ArticleId IdType="pubmed">19657394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RR, Fallini C, Gatto R, McKeon JE, Song Y, Rotunno MS, Penaranda S, Abdurakhmanov I, Landers JE, Morfini G, Brady ST, and Bosco DA (2017) ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci Rep 7, 115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, and Cardona A.(2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 676&#x2013;682</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Buss F, Kent H, Stewart M, Bailer SM, and Hanover JA (1994) Role of different domains in the self-association of rat nucleoporin p62. J Cell Sci 107 ( Pt 2), 631&#x2013;638</Citation><ArticleIdList><ArticleId IdType="pubmed">8207085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewangan PS, Sonawane PJ, Chouksey AR, and Chauhan R.(2017) The Nup62 Coiled-Coil Motif Provides Plasticity for Triple-Helix Bundle Formation. Biochemistry 56, 2803&#x2013;2811</Citation><ArticleIdList><ArticleId IdType="pubmed">28406021</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, Bickle M, Rizk S, Guillen-Boixet J, Franzmann TM, Jahnel M, Marrone L, Chang YT, Sterneckert J, Tomancak P, Hyman AA, and Alberti S.(2018) RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360, 918&#x2013;921</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter DSW, Rao BS, Van Treeck B, Lin Y, Mizoue L, Rosen MK, and Parker R.(2018) Intrinsically Disordered Regions Can Contribute Promiscuous Interactions to RNP Granule Assembly. Cell Rep 22, 1401&#x2013;1412</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5824733</ArticleId><ArticleId IdType="pubmed">29425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosinski J, Mosalaganti S, von Appen A, Teimer R, DiGuilio AL, Wan W, Bui KH, Hagen WJ, Briggs JA, Glavy JS, Hurt E, and Beck M.(2016) Molecular architecture of the inner ring scaffold of the human nuclear pore complex. Science 352, 363&#x2013;365</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926079</ArticleId><ArticleId IdType="pubmed">27081072</ArticleId></ArticleIdList></Reference><Reference><Citation>Krainer G, Welsh TJ, Joseph JA, Espinosa JR, Wittmann S, de Csillery E, Sridhar A, Toprakcioglu Z, Gudiskyte G, Czekalska MA, Arter WE, Guillen-Boixet J, Franzmann TM, Qamar S, George-Hyslop PS, Hyman AA, Collepardo-Guevara R, Alberti S, and Knowles TPJ (2021) Reentrant liquid condensate phase of proteins is stabilized by hydrophobic and non-ionic interactions. Nat Commun 12, 1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889641</ArticleId><ArticleId IdType="pubmed">33597515</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, Knowles T, Vendruscolo M, George-hyslop PS, Qamar S, Wang G, Randle SJ, Ruggeri FS, and Varela JA (2018) FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation- p Article FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation- p Interactions. 10.1016/j.cell.2018.03.056, 720&#x2013;734</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka S, and Ellenberg J.(2018) Mechanisms of nuclear pore complex assembly - two different ways of building one molecular machine. FEBS Lett 592, 475&#x2013;488</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6220763</ArticleId><ArticleId IdType="pubmed">29119545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallegger M, Chakrabarti AM, Lee FCY, Lee BL, Amalietti AG, Odeh HM, Copley KE, Rubien JD, Portz B, Kuret K, Huppertz I, Rau F, Patani R, Fawzi NL, Shorter J, Luscombe NM, and Ule J.(2021) TDP-43 condensation properties specify its RNA-binding and regulatory repertoire. Cell 184, 4680&#x2013;4696 e4622</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445024</ArticleId><ArticleId IdType="pubmed">34380047</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott TJ, Petsalaki E, Farber P, Jervis D, Fussner E, Plochowietz A, Craggs TD, Bazett-Jones DP, Pawson T, Forman-Kay JD, and Baldwin AJ (2015) Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol Cell 57, 936&#x2013;947</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4352761</ArticleId><ArticleId IdType="pubmed">25747659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, Mirzaei H, Goldsmith EJ, Longgood J, Pei J, Grishin NV, Frantz DE, Schneider JW, Chen S, Li L, Sawaya MR, Eisenberg D, Tycko R, and Mcknight SL (2012) Cell-free Formation of RNA Granules : Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels. Cell 149, 753&#x2013;767</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Qamar S, Lin JQ, Kaminski CF, George-hyslop PS, Murakami T, Qamar S, Lin JQ, Schierle GSK, Rees E, Li Y, Yang S. p., Wakutani Y, Meadows W, Ferry RR, and Dong L.(2015) Article ALS / FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function Article ALS / FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogel. 10.1016/j.neuron.2015.10.030, 678&#x2013;690</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, and Gitler AD (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9, e1000614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM, Kaushansky LJ, Ward CL, Sama RRK, Chian R-J, Boggio KJ, Quaresma AJC, Nickerson JA, and Bosco DA (2013) Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics. Molecular neurodegeneration 8, 30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766239</ArticleId><ArticleId IdType="pubmed">24090136</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin FE, Lukavsky PJ, Kazeeva T, Reber S, Hock EM, Colombo M, Von Schroetter C, Pauli P, Clery A, Muhlemann O, Polymenidou M, Ruepp MD, and Allain FH (2019) The Solution Structure of FUS Bound to RNA Reveals a Bipartite Mode of RNA Recognition with Both Sequence and Shape Specificity. Mol Cell 73, 490504 e496</Citation><ArticleIdList><ArticleId IdType="pubmed">30581145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarra A, and Hetzer MW (2015) Nuclear pore proteins and the control of genome functions. Genes Dev 29, 337&#x2013;349</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335290</ArticleId><ArticleId IdType="pubmed">25691464</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ, Guo L, Calder CB, Wills ZP, Pandey UB, Kofler JK, Brodsky JL, Thathiah A, Shorter J, and Donnelly CJ (2019) RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron 102, 321&#x2013;338 e328</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, Meally RO, Dignon GL, Conicella AE, Zheng W, Best RB, Cole RN, Mittal J, Shewmaker F, and Fawzi NL (2017) Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. 36, 2951&#x2013;2967</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz JC, Wang X, Podell ER, and Cech TR (2013) RNA seeds higher-order assembly of FUS protein. Cell Rep 5, 918&#x2013;925</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke H, Han M, Kim J, Gustin KE, and Yoo D.(2019) Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1 Beta Interacts with Nucleoporin 62 To Promote Viral Replication and Immune Evasion. J Virol 93</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6600190</ArticleId><ArticleId IdType="pubmed">31043527</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan DWA, and Jones DT (2019) The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res 47, W402&#x2013;W407</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602445</ArticleId><ArticleId IdType="pubmed">31251384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DT, and Cozzetto D.(2015) DISOPRED3: precise disordered region predictions with annotated protein-binding activity. Bioinformatics 31, 857&#x2013;863</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380029</ArticleId><ArticleId IdType="pubmed">25391399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry J, Chuguransky S, Williams L, Qureshi M, Salazar GA, Sonnhammer ELL, Tosatto SCE, Paladin L, Raj S, Richardson LJ, Finn RD, and Bateman A.(2021) Pfam: The protein families database in 2021. Nucleic Acids Res 49, D412D419</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779014</ArticleId><ArticleId IdType="pubmed">33125078</ArticleId></ArticleIdList></Reference><Reference><Citation>Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, Christie CH, Dalenberg K, Di Costanzo L, Duarte JM, Dutta S, Feng Z, Ganesan S, Goodsell DS, Ghosh S, Green RK, Guranovic V, Guzenko D, Hudson BP, Lawson CL, Liang Y, Lowe R, Namkoong H, Peisach E, Persikova I, Randle C, Rose A, Rose Y, Sali A, Segura J, Sekharan M, Shao C, Tao YP, Voigt M, Westbrook JD, Young JY, Zardecki C, and Zhuravleva M.(2021) RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res 49, D437&#x2013;D451</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779003</ArticleId><ArticleId IdType="pubmed">33211854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehnal D, Bittrich S, Deshpande M, Svobodova R, Berka K, Bazgier V, Velankar S, Burley SK, Koca J, and Rose AS (2021) Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures. Nucleic Acids Res 49, W431&#x2013;W437</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262734</ArticleId><ArticleId IdType="pubmed">33956157</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice P, Longden I, and Bleasby A.(2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16, 276&#x2013;277</Citation><ArticleIdList><ArticleId IdType="pubmed">10827456</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>